The world's leading start-up accelerator programme for life sciences

MedCity is partnering with the Oxbridge Biotech Roundtable and SR One on OneStart, an annual business accelerator programme and competition aimed at biotech entrepreneurs under the age of 35.

Set up in 2013, OneStart is the world’s largest business plan competition with two parallel strands in Europe and the USA. The winning business claims £100,000 in Europe and $150,000 in America, plus free lab space, and business and IP support.

The final 35 semi-finalists also take part in Biotech Business Bootcamp, an intense mini-MBA programme, where they pitch directly to potential investors. The competition has a strong track record of seeding new companies, with over 40 entrants in the past two years going on to raise financing of between £75k to £3m thanks to the contacts and support of the programme.

Find out more and enter.

Read more about latest OneStart winner Keregen.